ClinicalTrials.Veeva

Menu

Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study

University of Florida logo

University of Florida

Status

Completed

Conditions

Intracranial Aneurysm

Treatments

Device: Ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT02684500
IRB201500830

Details and patient eligibility

About

The purpose of this research study is to determine if the diameter and flow of the superior mesenteric artery in patients with aneurysmal subarachnoid hemorrhage undergoing hypertensive therapy for cerebral artery vasospasm are effected enough to justify withholding enteral nutrition.

Full description

Study measurements of the diameter and Doppler flow velocity of the superior mesenteric artery (SMA) using abdominal ultrasound in order to evaluate the potential additional risk of non-occlusive mesenteric ischemia (NOMI) and non occlusive bowel necrosis (NOBN) in patients undergoing hypertensive therapy for cerebral vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH), to justify the withholding of enteral nutrition.

Enrollment

14 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient diagnosed with aSAH

Exclusion criteria

  • Hemodynamic instability
  • Already receiving vasopressor therapy
  • Non-aneurysmal SAH
  • Intracranial hemorrhage of other cause
  • Not anticipated to receive hypertensive therapy with vasoactive medications for cerebral vasospasm from SAH or suspected aSAH
  • Unable to visualize SMA using ultrasound
  • Pregnancy

Trial design

14 participants in 1 patient group

aneurysmal subarachnoid hemorrhage
Description:
Study measurements of the diameter and doppler flow velocity of the superior mesenteric artery (SMA) using abdominal ultrasound in order to evaluate the potential additional risk of non-occlusive mesenteric ischemia (NOMI) and non occlusive bowel necrosis (NOBN) for a aneurysmal subarachnoid hemorrhage in subjects undergoing hypertensive therapy for cerebral vasospasm in SAH, to justify the withholding of enteral nutrition.
Treatment:
Device: Ultrasound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems